Stay updated with breaking news from Yves Chatelan. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Ad hoc announcement pursuant to Art. 53 LR Allschwil, Switzerland - May 21, 2024 Idorsia Ltd (SIX: IDIA) today announced its financial results for the first quarter of 2024. Business highlights Viatris
Investegate announcements from Idorsia Pharmaceuticals Ltd, Idorsia expands its commercialization partnership with Syneos Health for daridorexant in Europe and Canada
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Idorsia Ltd (SIX: IDIA), a leading Swiss biopharmaceutical company, and Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced the extension of an existing collaboration to commercialize daridorexant, a novel dual orexin receptor antagonist for the ...